Topical Diclofenac to Manage Opioid-Refractory Pain in a Rare Pancreatic Fibrosarcoma

J Palliat Med. 2024 Apr;27(4):576-578. doi: 10.1089/jpm.2023.0339. Epub 2023 Sep 11.

Abstract

Pancreatic cancer is often diagnosed at an advanced stage and is frequently associated with severe pain. Traditional pain management in this condition may be improved with the use of topical diclofenac. A 39-year-old man with advanced pancreatic fibrosarcoma metastatic to the thoracic spine presented to the hospital with severe abdominal pain refractory to escalating doses of opioids. A celiac plexus block produced significant, yet inadequate, pain reduction. Satisfactory pain control and opioid de-escalation were ultimately achieved with the application of topical diclofenac gel to an area of bony metastasis. This case illustrates the potential for pain control using topical diclofenac in patients with pancreatic soft tissue tumors and vertebral metastases. Topical diclofenac may exert antitumoral effects and targeted application may improve absorption, leading to improved pain control. The use of topical diclofenac for pain management in metastatic pancreatic cancer presents an interesting tool that should be considered in similar cases.

Keywords: celiac plexus block; diclofenac; opioid-refractory pain; pancreatic fibrosarcoma.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Analgesics, Opioid / therapeutic use
  • Anti-Inflammatory Agents, Non-Steroidal
  • Celiac Plexus*
  • Diclofenac / therapeutic use
  • Humans
  • Male
  • Pain Management
  • Pain, Intractable* / drug therapy
  • Pancreatic Neoplasms* / complications
  • Pancreatic Neoplasms* / drug therapy

Substances

  • Diclofenac
  • Analgesics, Opioid
  • Anti-Inflammatory Agents, Non-Steroidal